Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-Sep-24 5:15 PM View:  | Eli Lilly & Co. (LLY) | 16-Sep-24 | Grant | 10 | $923.54 | $9,235.40 | < 1% 2.68K to 2.69K | |
| 20-Aug-24 4:15 PM View: | Eli Lilly & Co. (LLY) | 19-Aug-24 | Grant | 10 | $921.81 | $9,218.10 | < 1% 2.66K to 2.67K | |
| 16-Jul-24 4:20 PM View: | Eli Lilly & Co. (LLY) | 15-Jul-24 | Grant | 10 | $950.46 | $9,504.60 | < 1% 2.65K to 2.66K | |
| 18-Jun-24 4:20 PM View: | Eli Lilly & Co. (LLY) | 17-Jun-24 | Grant | 11 | $885.01 | $9,735.11 | < 1% 2.64K to 2.65K | |
| 21-May-24 4:21 PM View: | Eli Lilly & Co. (LLY) | 20-May-24 | Grant | 12 | $783.18 | $9,398.16 | < 1% 2.63K to 2.64K | |
| 02-May-24 12:09 PM View: | T. Rowe Price Group, Inc. (TROW) | 02-May-24 | Grant | 164 | $112.45 | $18,468.20 | < 1% 36.16K to 36.32K | |
| 02-May-24 12:09 PM View: | T. Rowe Price Group, Inc. (TROW) | 02-May-24 | Payment of Exercise | 601 | $110.30 | $66,290.30 | (2%) 36.32K to 35.72K | |
| 16-Apr-24 4:12 PM View: | Eli Lilly & Co. (LLY) | 15-Apr-24 | Grant | 13 | $750.77 | $9,760.01 | < 1% 2.61K to 2.63K | |
| 19-Mar-24 4:19 PM View: | Eli Lilly & Co. (LLY) | 18-Mar-24 | Grant | 13 | $762.66 | $9,914.58 | < 1% 2.6K to 2.61K | |
| 21-Feb-24 4:18 PM View: | Eli Lilly & Co. (LLY) | 20-Feb-24 | Grant | 13 | $755.66 | $9,823.58 | < 1% 2.58K to 2.6K | |
| 17-Jan-24 4:15 PM View: | Eli Lilly & Co. (LLY) | 16-Jan-24 | Grant | 15 | $634.57 | $9,518.55 | < 1% 2.57K to 2.58K | |
| 19-Dec-23 4:13 PM View: | Eli Lilly & Co. (LLY) | 18-Dec-23 | Grant | 17 | $579.76 | $9,855.92 | < 1% 2.55K to 2.57K | |
| 11-Dec-23 3:14 PM View: | T. Rowe Price Group, Inc. (TROW) | 08-Dec-23 | Payment of Exercise | 596 | $99.94 | $59,564.20 | (2%) 36.75K to 36.16K | |
| 07-Dec-23 2:26 PM View: | T. Rowe Price Group, Inc. (TROW) | 05-Dec-23 | Grant | 17,124 | $1.35 | $23,164.30 | 87% 19.63K to 36.75K | |
| 21-Nov-23 10:00 PM View: | Eli Lilly & Co. (LLY) | 20-Nov-23 | Grant | 351 | $597.60 | $209,758.00 | 16% 2.2K to 2.55K | |
| 17-Oct-23 4:21 PM View: | Eli Lilly & Co. (LLY) | 16-Oct-23 | Grant | 16 | $616.64 | $9,866.24 | < 1% 2.18K to 2.2K | |
| 20-Sep-23 4:27 PM View: | Eli Lilly & Co. (LLY) | 18-Sep-23 | Grant | 17 | $571.28 | $9,711.76 | < 1% 2.16K to 2.18K | |
| 22-Aug-23 4:29 PM View: | Eli Lilly & Co. (LLY) | 21-Aug-23 | Grant | 18 | $550.50 | $9,909.00 | < 1% 2.14K to 2.16K | |
| 18-Jul-23 4:33 PM View: | Eli Lilly & Co. (LLY) | 17-Jul-23 | Grant | 22 | $447.14 | $9,837.08 | 1% 2.12K to 2.14K | |
| 21-Jun-23 4:25 PM View: | Eli Lilly & Co. (LLY) | 20-Jun-23 | Grant | 21 | $451.95 | $9,490.95 | 1% 2.1K to 2.12K | |
| 16-May-23 4:26 PM View: | Eli Lilly & Co. (LLY) | 15-May-23 | Grant | 22 | $434.51 | $9,559.22 | 1% 2.07K to 2.09K | |
| 02-May-23 12:51 PM View: | T. Rowe Price Group, Inc. (TROW) | 02-May-23 | Grant | 155 | $112.31 | $17,459.50 | < 1% 20.08K to 20.23K | |
| 02-May-23 12:51 PM View: | T. Rowe Price Group, Inc. (TROW) | 02-May-23 | Payment of Exercise | 607 | $111.31 | $67,565.20 | (3%) 20.23K to 19.63K | |
| 19-Apr-23 4:30 PM View: | Eli Lilly & Co. (LLY) | 17-Apr-23 | Grant | 26 | $372.35 | $9,681.10 | 1% 2.05K to 2.07K | |
| 22-Mar-23 4:13 PM View: | Eli Lilly & Co. (LLY) | 20-Mar-23 | Grant | 29 | $333.60 | $9,674.40 | 1% 2.02K to 2.05K | |
| 22-Feb-23 4:57 PM View: | Eli Lilly & Co. (LLY) | 21-Feb-23 | Grant | 30 | $327.51 | $9,825.30 | 2% 1.98K to 2.01K | |
| 19-Jan-23 4:44 PM View: | Eli Lilly & Co. (LLY) | 17-Jan-23 | Grant | 27 | $357.74 | $9,658.98 | 1% 1.95K to 1.98K | |
| 20-Dec-22 5:12 PM View: | Eli Lilly & Co. (LLY) | 19-Dec-22 | Grant | 27 | $357.78 | $9,660.06 | 1% 1.93K to 1.95K | |
| 08-Dec-22 4:17 PM View: | T. Rowe Price Group, Inc. (TROW) | 06-Dec-22 | Grant | 10,102 | $2.44 | $24,672.20 | 101% 9.98K to 20.08K | |
| 22-Nov-22 5:36 PM View: | Eli Lilly & Co. (LLY) | 21-Nov-22 | Grant | 525 | $361.17 | $189,614.00 | 38% 1.4K to 1.92K | |
| 19-Oct-22 4:17 PM View: | Eli Lilly & Co. (LLY) | 17-Oct-22 | Grant | 29 | $332.76 | $9,650.04 | 2% 1.37K to 1.4K | |
| 21-Sep-22 4:40 PM View: | Eli Lilly & Co. (LLY) | 19-Sep-22 | Grant | 32 | $305.09 | $9,762.88 | 2% 1.34K to 1.37K | |
| 16-Aug-22 4:20 PM View: | Eli Lilly & Co. (LLY) | 15-Aug-22 | Grant | 31 | $313.94 | $9,732.14 | 2% 1.3K to 1.33K | |
| 19-Jul-22 8:07 PM View: | Eli Lilly & Co. (LLY) | 18-Jul-22 | Grant | 30 | $321.77 | $9,653.10 | 2% 1.27K to 1.3K | |
| 22-Jun-22 5:37 PM View: | Eli Lilly & Co. (LLY) | 21-Jun-22 | Grant | 33 | $297.34 | $9,812.22 | 3% 1.24K to 1.27K | |
| 18-May-22 4:48 PM View: | Eli Lilly & Co. (LLY) | 16-May-22 | Grant | 32 | $299.38 | $9,580.16 | 3% 1.2K to 1.23K | |
| 03-May-22 1:03 PM View: | T. Rowe Price Group, Inc. (TROW) | 02-May-22 | Grant | 9,978 | -- | -- | 100% 0 to 9.98K | |
| 19-Apr-22 4:25 PM View: | Eli Lilly & Co. (LLY) | 18-Apr-22 | Grant | 32 | $298.82 | $9,562.24 | 3% 1.17K to 1.2K | |
| 22-Mar-22 4:58 PM View: | Eli Lilly & Co. (LLY) | 21-Mar-22 | Grant | 33 | $289.64 | $9,558.12 | 3% 1.14K to 1.17K | |
| 24-Feb-22 5:06 PM View: | Eli Lilly & Co. (LLY) | 22-Feb-22 | Grant | 40 | $239.13 | $9,565.20 | 4% 1.09K to 1.13K | |
| 20-Jan-22 5:23 PM View: | Eli Lilly & Co. (LLY) | 18-Jan-22 | Grant | 39 | $247.07 | $9,635.73 | 4% 1.05K to 1.09K | 5% |
| 22-Dec-21 4:29 PM View: | Eli Lilly & Co. (LLY) | 20-Dec-21 | Grant | 37 | $263.48 | $9,748.76 | 4% 1.02K to 1.05K | < 1% |
| 17-Nov-21 5:25 PM View: | Eli Lilly & Co. (LLY) | 15-Nov-21 | Grant | 658 | $258.43 | $170,047.00 | 185% 0.36K to 1.01K | (< 1%) |
| 20-Oct-21 4:09 PM View: | Eli Lilly & Co. (LLY) | 18-Oct-21 | Grant | 40 | $238.98 | $9,559.20 | 13% 0.31K to 0.35K | 1% |
| 22-Sep-21 10:00 PM View: | Eli Lilly & Co. (LLY) | 20-Sep-21 | Grant | 42 | -- | -- | 15% 0.27K to 0.31K | |
| 17-Aug-21 10:00 PM View: | Eli Lilly & Co. (LLY) | 16-Aug-21 | Grant | 36 | $269.94 | $9,717.84 | 15% 0.23K to 0.27K | 1% |
| 21-Jul-21 4:10 PM View: | Eli Lilly & Co. (LLY) | 19-Jul-21 | Grant | 41 | $234.14 | $9,599.74 | 21% 0.19K to 0.23K | < 1% |
| 23-Jun-21 4:37 PM View: | Eli Lilly & Co. (LLY) | 21-Jun-21 | Grant | 43 | $222.67 | $9,574.81 | 28% 0.15K to 0.19K | (< 1%) |
| 19-May-21 4:30 PM View: | Eli Lilly & Co. (LLY) | 17-May-21 | Grant | 49 | $195.53 | $9,580.97 | 48% 0.1K to 0.15K | (< 1%) |
| 21-Apr-21 4:27 PM View: | Eli Lilly & Co. (LLY) | 19-Apr-21 | Grant | 51 | $189.64 | $9,671.64 | 100% 51 to 0.1K | < 1% |